Clinical Trials Logo

Age Over 80 Years clinical trials

View clinical trials related to Age Over 80 Years.

Filter by:
  • None
  • Page 1

NCT ID: NCT04622579 Recruiting - Clinical trials for Diffuse Large B Cell Lymphoma

Lenalidomide Combined With Rituximab as Front-line Therapy for DLBCL Patients Aged Over 80 Years

R2DLBCL80
Start date: October 23, 2020
Phase: Phase 2
Study type: Interventional

About 40% of Diffuse large B cell lymphoma relapse or is refractory, age is a prognostic factor of DLBCL, as elderly patients are not capable to received standard treatment, the prognosis of elderly patients is poor especially those aged over 80 years. In this study,we aimed to investigate the safety and efficacy of the combination of lenalidomide and rituximab in elderly patients aged ≥ 80 years with untreated DLBCL.